Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.clbc.2025.03.003
dc.identifier.other
WOS:001513877300025
dc.description.volume
dc.description.issue
Publisher
CIG MEDIA GROUP, LP
DOI
10.1016/j.clbc.2025.03.003